The inhaled nitric oxide (NO) delivery system market is poised for steady growth due to its increasing use in critical care settings, particularly in the treatment of respiratory conditions such as pulmonary hypertension and acute respiratory distress syndrome (ARDS). Inhaled nitric oxide has...